Inflammation Signaling Pathways – Functions, Disease Implications and Biomarker Analysis
What are inflammation signaling pathways?
Inflammation signaling pathways are interconnected molecular cascades that coordinate the immune system’s response to infection, tissue injury, and cellular stress. These pathways translate extracellular danger signals into transcriptional programs that regulate cytokine production, immune cell activation, tissue repair, and resolution of inflammation.
Physiological inflammation is essential for host defense and homeostasis. However, persistent or dysregulated inflammatory signaling drives the development of numerous chronic diseases, including autoimmune disorders, cancer, cardiovascular diseases, and neurodegenerative conditions.
Inflammatory pathway activity can be effectively studied through targeted gene expression analysis, enabling the identification of disease-associated biomarkers and therapeutic targets.
Precise molecular profiling is essential to guide targeted interventions.
Why study inflammation signaling pathways with AnyGenes?
At AnyGenes®, we provide high-performance qPCR arrays and customizable SignArrays® designed for inflammation signaling pathway analysis and biomarker discovery.
By measuring the expression of pathway regulators and downstream targets using targeted gene expression approaches such as qPCR pathway arrays.
Miguel Lourenço Varela et al. Acute Inflammation and Metabolism. Inflammation. (2018);41(4):1115-1127.
Yu W, et al. Advances in T Cells Based on Inflammation in Metabolic Diseases. Cells. (2022)10;11(22):3554.
Luis F García. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Front Immunol. (2020);11:1441.
Michele Catanzaro et al. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct Target Ther. (2020);5(1):84.
Ning Yuan et al. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry. (2019);9(1):233.
Estella A Newcombe et al. Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease. J Neuroinflammation. 2018;15(1):276.
Christina H Liu et al. Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities. Nat Immunol. 2017;18(11):1175-1180.
Peter Libby and Sebastian Kobold. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology. Cardiovasc Res. 2019;115(5): 824–829.
Zarrin AA, et al. Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov. (2021);20(1):39-63.
Inflammation signaling pathway biomarker list
You can check the biomarker list included in this pathway, see below: